Article in Oncoimmunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Hannelore CeuppensVrije Universiteit Brussel, Department of Biomedical Sciences, Translational Oncology Research Center, Laboratory for Molecular and Cellular Therapy, Brussels, Belgium.ORCID 0000-0003-0187-4204
Kirsten De RidderVrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.ORCID 0000-0003-1482-1742
Thomas ErtveldtVrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.ORCID 0000-0001-7825-7808
Katty ZevenVrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.ORCID 0000-0002-6637-6217
Wout De MeyVrije Universiteit Brussel, Department of Biomedical Sciences, Translational Oncology Research Center, Laboratory for Molecular and Cellular Therapy, Brussels, Belgium.ORCID 0000-0002-5747-101X
Ana Rita Pombo AntunesPrecirix NV/SA, Brussels, Belgium.
Laurent NavarroPrecirix NV/SA, Brussels, Belgium.
Nina DumauthiozPrecirix NV/SA, Brussels, Belgium.
Tony LahoutteVrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.ORCID 0000-0002-1773-8664
Jens M DebackerVrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.ORCID 0000-0002-8293-2885
Nick DevoogdtVrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.ORCID 0000-0001-9220-4833
Marleen KeyaertsVrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.ORCID 0000-0002-9997-4571
Matthias D'HuyvetterVrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.ORCID 0000-0002-6895-4260
Cleo GoyvaertsVrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.ORCID 0000-0002-1725-7772
Karine BreckpotVrije Universiteit Brussel, Department of Biomedical Sciences, Translational Oncology Research Center, Laboratory for Molecular and Cellular Therapy, Brussels, Belgium.ORCID 0000-0003-4331-3480
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Immune modulation following α and β · full record | OpenQuestion